Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Opinion Article - Journal of Infectious Diseases and Medical Microbiology (2025) Volume 9, Issue 1

Viral Genome Sequencing: Unraveling the Secrets of Viruses

Deng Palese*

Department of Internal Medicine, Kaohsiung, Taiwan

*Corresponding Author:
Deng Palese
Department of Internal Medicine, Kaohsiung, Taiwan
E-mail: depalese@yahoo.com

Received: : 01-Jan-2025, Manuscript No. AAJIDMM - 25-161884; Editor assigned: 05-Jan-2025, PreQC No. AAJIDMM - 25-161884 (PQ); Reviewed: 19-Jan-2025, QC No. AAJIDMM - 25-161884; Revised:22-Jan-2025, Manuscript No. AAJIDMM - 25-161884 (R); Published:29-Jan-2025, DOI:10.35841/10.35841/ aajidmm-9.1.249

Citation: Citation: Palese D. Viral Genome Sequencing: Unraveling the secrets of viruses. J Infect Dis Med Microbiol. 2025; 9(1):249

Introduction

Viral genome sequencing has emerged as a critical tool in modern virology, offering profound insights into the genetic makeup of viruses, their evolution, transmission patterns, and their interactions with host organisms. [

The advent of nextgeneration sequencing (NGS) technologies has revolutionized our ability to sequence and analyse viral genomes, providing a comprehensive understanding of viral biology and the molecular basis of viral diseases. This has become particularly important in the context of emerging infectious diseases, such as COVID-19, Zika virus, and Ebola, where rapid sequencing can inform diagnosis, treatment strategies, and public health responses.[2].

Viral genome sequencing is the process of determining the complete genetic material (DNA or RNA) of a virus. This involves extracting viral RNA or DNA from infected samples, amplifying it, and then determining the nucleotide sequence using high-throughput sequencing technologies. [3].

The viral genome can provide detailed information about the virus’s structure, replication mechanisms, and the specific genes responsible for pathogenicity. Viral genomes can be classified based on their structure and replication strategy. Some viruses have single-stranded RNA genomes (e.g., coronaviruses), while others have double-stranded DNA genomes (e.g., herpesviruses). Sequencing the genome of a virus allows scientists to identify specific genetic mutations, track the virus's evolutionary history, and monitor genetic changes that could impact transmission and virulence [4, 5].

The first step is obtaining a sample from a patient or environmental source. This could include blood, respiratory secretions, saliva, faeces, or other bodily fluids, depending on the virus of interest. Once the sample is collected, viral particles are isolated, and the viral RNA or DNA is extracted. [6].

Since viruses often exist in low quantities in biological samples, amplification techniques such as polymerase chain reaction (PCR) or reverse-transcription PCR (RT-PCR) are used to increase the amount of viral nucleic acid. This allows for sufficient material to be sequenced and analysed. Once sufficient viral material is obtained, next-generation sequencing (NGS) platforms are used to read the nucleotide sequence of the viral genome. NGS platforms, such as Illumina, Oxford Nanopore, and PacBio, can generate massive amounts of sequencing data in a short period, allowing researchers to obtain near-complete viral genomes quickly. After sequencing, bioinformatics tools are used to analyze the massive data sets generated. These tools help assemble the genome sequence, identify mutations, compare the viral genome to existing databases, and construct phylogenetic trees to understand the virus's evolution and relatedness to other strains [7].

Viral genome sequencing has a wide range of applications, particularly in the fields of infectious disease diagnosis, outbreak tracking, vaccine development, and antiviral drug discovery. Viral genome sequencing can be used to identify novel or rare viruses that may not be detectable by conventional diagnostic methods, sequencing the genome of a new virus like SARS-CoV-2 (the virus responsible for COVID-19) allows for the rapid identification of its genetic makeup, helping to confirm its identity and understand its transmission dynamics. In cases where traditional diagnostic tests (e.g., PCR, serology) fail or are not available, genome sequencing provides a definitive diagnosis by identifying viral genetic material in patient samples. [8].

Although sequencing technologies have become more accessible, the cost of sequencing remains a significant barrier, especially for low-resource settings. However, ongoing improvements in sequencing technology and the availability of NGS platforms are expected to reduce the cost of viral genome sequencing over time [9].

Viral genome sequencing generates vast amounts of data, and analysing this data can be complex. Bioinformatics expertise is required to accurately interpret the results and identify relevant genetic mutations, especially when comparing large numbers of viral genomes. The quality of the viral genome sequence can be compromised by contamination from host DNA or other microorganisms present in patient samples. Ensuring the purity of viral RNA or DNA is crucial to obtaining accurate results. As viruses evolve and mutate, tracking new variants becomes increasingly challenging. While sequencing can identify mutations, the long-term consequences of those mutations—such as changes in infectivity, immune escape, or drug resistance—can be difficult to predict without further research. [10].

conclusion

Viral genome sequencing has transformed our understanding of viruses and how they interact with hosts. From diagnosing infections to tracking outbreaks, designing vaccines, and developing antiviral drugs, viral genome sequencing plays a vital role in modern virology. Despite challenges such as cost and data analysis, the continued advancement of sequencing technologies and their integration with cutting-edge bioinformatics tools promise to further accelerate our ability to respond to viral threats. As new viruses emerge and existing ones evolve, the ability to rapidly sequence viral genomes will be indispensable in safeguarding global health and ensuring effective treatments for viral diseases.

References

  1. García-Montero C, Fraile-Martínez O, Gómez-Lahoz AM, et al. Nutritional components in Western diet versus Mediterranean diet at the gut microbiota–immune system interplay. Implications for health and disease.Nutrients.2021;13(2):699.

    2. Indexed at, Google Scholar, Cross Ref

  2. Davis EC, Castagna VP, Sela DA, et al. Gut microbiome and breast-feeding: Implications for early immune development. J Allergy Clin Immuno2022;150(3):523-34.

    3. Indexed at, Google Scholar, Cross Ref

  3. Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003-17.

    4. Indexed at, Google Scholar, Cross Ref

  4. Federici S, Kviatcovsky D, Valdés-Mas R, et al. Microbiome-phage interactions in inflammatory bowel disease. Clin Microbiol Infect. 2023;29(6):682-8.

    5. Indexed at, Google Scholar, Cross Ref 

  5. Genco RJ, Sanz M. Clinical and public health implications of periodontal and systemic diseases: An overview. Periodontol 2000. 2020;83(1):7-13.

    6. Indexed at, Google Scholar, Cross Ref

  6. Hanson MA. When the microbiome shapes the host: immune evolution implications for infectious disease. Philos Trans R Soc Lond B Biol Sci. 2024;379(1901):20230061.

    7. Indexed at, Google Scholar, Cross Ref

  7. Martínez M, Postolache TT, García-Bueno B, et al. The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma-and stress-related disorders. Front Psychiatry. 2022;12:814177.

    8. Indexed at, Google Scholar, Cross Ref

  8. Schluter J, Peled JU, Taylor BP, et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588(7837):303-7.

    9. Indexed at, Google Scholar, Cross Ref

  9. Ladner JT, Grubaugh ND, Pybus OG, et al. Precision epidemiology for infectious disease control. Nat Med.2019;25(2):206-11.

    10. Indexed at, Google Scholar, Cross Ref

  10. Thompson KN, Bonham KS, Ilott NE, et al. Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes. Sci Transl Med. 2023;15(706):eabn4722.

    11. Indexed at, Google Scholar, Cross Ref

Get the App